Acute cocaine effects on stereotypy and defense: An ethoexperimental approach

Neuroscience and Biobehavioral Reviews

Volumn 23, Issue 2, 1998, Pages 179-188

  Blanchard, Robert J ^a   Hebert, Mark A ^b   Dulloog, Lanelle ^b   Nohea Kaawaloa, ^b   Nishimura, Owen ^b   Caroline Blanchard, D ^c  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

Anxiety; Cocaine; Defensive behavior; Panic; Rat; Rearing; Sniffing; Stereotypy

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ANXIETY; COCAINE DEPENDENCE; CONFERENCE PAPER; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; ETHOLOGY; GROOMING; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; RECUMBENCY; SNIFFING; STEREOTYPY;

EID: 0032442761     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(98)00019-0     Document Type: Conference Paper

References (32)

1. Simon P., Dupuis R., Costentin J. Thigmotaxis as an index of anxiety in mice: influence of dopaminergic transmissions. Behav. Brain Res. 61:1994;59-64.
2. Costall B., Kelly M.E., Naylor R.J., Onaivi E.S. The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol. Biochem. Behav. 33:1989;197-203.
3. Yang W.M., Gorman A.L., Dunn A.J., Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Pharmacol. Biochem. Behav. 41:1992;643-650.
4. Rogerio R., Takahashi R.N. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze. Pharmacol. Biochem. Behav. 43:1992;631-633.
5. Ettenberg A., Geist T.D. Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology. 103:1991;455-461.
6. Sarnyai Z. Measurement of cocaine-induced stereotyped behavior in response to neuropeptides. In: Conn MP, editor. Paradigms for the study of behavior. Methods in neurosciences. New York: Academic Press, 1993. pp. 153-165.
7. Scheel-Kruger J, Braestrup C, Nielson M, Golembiowska K, Mogilnicka E. In: Ellinwood EH Jr, Kilbey MM, editors. Cocaine and other stimulants. New York: Plenum, 1975. p. 373.
8. Ujike H., Akiyama K., Otsuki S. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacol. 102:1990;459-464.
9. Broderick P.A. Cocaine: on-line analysis of an accumbens amine neural basis for psychomotor behavior. Pharmacol. Biochem. Behav. 40:1991;959-968.
10. Blanchard R.J., Shepherd J.K., Armstrong J., Tsuda S.F., Blanchard D.C. An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT. Psychopharmacol. (Berlin). 112:1993;55-65.
11. 1A receptors: the mouse 5-HT syndrome. Pharmacol. Biochem. Behav. 57:1997;897-908.
12. Laviola G., Wood R.D., Kuhn C., Francis R., Spear L.P. Cocaine sensitization in periadolescent and adult rats. J. Pharmacol. Exper. Therap. 275:1995;345-357.
13. Blanchard RJ, Blanchard DC, Hori K. Ethoexperimental approaches to the study of defensive behavior. In: Blanchard RJ, Brain PF, Blanchard DC, Parmigiani S, editors. Ethoexperimental approaches to the study of behavior. Dordrecht: Kluwer Academic Publishers, 1989. pp. 114-136.
14. Blanchard DC, Blanchard RJ, Rodgers RJ. Risk assessment and animal models of anxiety. In: Olivier B, Mos J, Slangen JL, editors. Animal models in psychopharmacology. Basel: Birkhauser Verlag AG, 1991. pp. 117-134.
15. Sarnyai Z., Hohn J., Szabo G., Penke B. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sci. 51:1992;2019-2024.
16. Gauvin D.V., Holloway F.A. Cue dimensionality in the three-choice pentylenetetrazole-saline-chlordiazepoxide discrimination task. Special Issue: behavioural aspects of drug discrimination. Behav. Pharmacol. 2:1991;417-428.
17. Wood D.M., Lal H. Anxiogenic properties of cocaine withdrawal. Life Sci. 41:1987;1431-1436.
18. Emmett Oglesby M.W., Wurst M., Lal H. Discriminative properties of a small dose of cocaine. Neuropharmacology. 22:1983;97-101.
19. Shearman G., Lal H. Discriminative stimulus properties of pentylenetetrazol and bemegride: some generalization and antagonism tests. Psychopharmacology. 64:1979;315-319.
20. Bystritsky A., Ackerman D.L., Pasnau R.O. Low dose desipramine treatment of cocaine-related panic attacks. J. Nerv. Ment. Dis. 179:1991;755-758.
21. Cox B.J., Norton G.R., Swinson R.P., Endler N.S. Substance abuse and panic-related anxiety: a critical review. Behav. Res. Ther. 28:1990;385-393.
22. Gawin F.H. Cocaine abuse and addiction. J. Family Practice. 29:1989;193-197.
23. Geracioti T.D., Post R.M. Onset of panic disorder associated with rare use of cocaine. Biol. Psychiat. 29:1991;403-406.
24. Strickland T.L., James R., Myers H., Lawson W. Psychological characteristics related to cocaine use during pregnancy: a postpartum assessment. J. Nat. Med. Assoc. 85:1993;758-760.
25. Husband S.D., Marlowe D.B., Lamb R.J., Iguchi M.Y. Decline in self-reported dysphoria after treatment entry in inner-city cocaine addicts. J. Consult. Clin. Psychol. 64:1996;221-224.
26. Serper M.R., Alpert M., Richardson N.A., Dickson S. Clinical effects of recent cocaine use on patients with acute schizophrenia. Am. J. Psychiat. 152:1995;1464-1469.
27. Griebel G., Blanchard D.C., Agnes R., Blanchard R.J. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute and chronic treatment with imipramine and fluoxetine. Psychopharmacology. 120:1995;57-66.
28. Griebel G., Blanchard D.C., Jung A., Lee J., Masuda C.K., Blanchard R.J. Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: Effects of acute and chronic treatment with alprazolam. Neuropharmacology. 34:1995;1625-1633.
29. Lacayo A. Neurologic and psychiatric complications of cocaine abuse. Neuropsychiat. Neuropsychol. Behav. Neurol. 8:1995;53-60.
30. George M.S., Ballenger J.C. The neuroanatomy of panic disorder: the emerging role of the right parahippocampal region. J. Anx. Dis. 6:1991;181-188.
31. McDugle C.J., Black J.E., Malison R.T., Zimmermann R.C., Kosten T.R., Heninger G.R., Price L.H. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch. Gen. Psychiat. 51:1994;713-719.
32. Rosen M.I., Kosten T.R. Cocaine-associated panic attacks in methadone-maintained patients. Am. J. Drug Alc. Abuse. 18:1992;57-62.